Stereotaxis Awarded U.S. Patent Covering Transmission of Data for Odyssey(R) Solutions
"We are pleased to receive this strategic patent, which could variously be applied to data generated when performing many different types of procedures within hospitals," said
The Company's Odyssey solution product line is used in conjunction with its Niobe® remote magnetic navigation system, the only commercialized technology proven to precisely steer a cardiac catheter tip using computer-controlled, externally applied magnetic fields. The Odyssey Vision™ and Odyssey Cinema™ systems, provide a consolidated user interface of all lab information during procedures performed using the Niobe system, as well as real-time or recorded viewing of procedures across networks and institutions.
The core components of
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the
CONTACT: STXS Company Contact:
Martin StammerChief Financial Officer 314-678-6155 STXS Investor Contact: Todd Kehrli/ Jim Byers MKR Group, Inc.323-468-2300 email@example.com